浙江圣达生物药业股份有限公司关于2024年员工持股计划完成非交易过户的公告

Core Viewpoint - Zhejiang Sandar Biopharmaceutical Co., Ltd. has completed the non-trading transfer of shares under its 2024 Employee Stock Ownership Plan (ESOP), with a total of 280,000 shares transferred at a price of 8.39 yuan per share, representing 0.15% of the company's total share capital [1][2]. Summary by Sections Employee Stock Ownership Plan - The 2024 Employee Stock Ownership Plan was approved by the company's board and shareholders, with 6 employees participating and subscribing to a total of 2,349,200 shares, corresponding to 280,000 shares of the company [1]. - The total subscription amount for the plan was 2,349,200 yuan, with each share priced at 1 yuan [1]. Share Transfer Details - The shares were transferred from the company's repurchase account to the ESOP account on October 29, 2025, at a price of 8.39 yuan per share [2]. - The total number of shares held under the ESOP is 280,000, which constitutes 0.15% of the company's total share capital [2]. Plan Duration and Unlocking Schedule - The ESOP has a duration of 48 months, starting from the date of the last share transfer to the plan [3]. - The unlocking of shares will occur in three phases after 12, 24, and 36 months, with 30%, 30%, and 40% of the shares being unlocked respectively [3].